KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Supercharging immune cells could provide an effective way to tackle cancer, according to new research by scientists in ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...

A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...